STOCK TITAN

Conexeu Sciences (CNXU) Stock Price, News & Analysis

CNXU NASDAQ
Published by Stock Titan Data refreshed

Price Move History

Daily moves over 5%
62 103 sessions, May 21, 2026 to October 16, 2026
Largest daily move
+27.5% close of June 16, 2026
1-month change
-33.8% closing prices, September 16, 2026 to October 16, 2026

Company Description

Conexeu Sciences (NASDAQ: CNXU) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $88.9M.

CNXU has declined 33.8% over the past month. The last closing price was $3.06.

This page collects what Stock Titan holds for CNXU, including price data, latest news, SEC filings, upcoming events, and short interest trends.

Stock Performance

$3.15
-20.25%
0.80
Last updated: October 16, 2026 at 18:43
-33.8%
Performance 1 month
$88.9M

Conexeu Sciences (CNXU) closed at $3.06 on October 16, 2026. Over the past month, the price has lost 33.8%.

See what a $1,000 investment in CNXU would be worth today

Average down calculator for CNXU

CNXU Metrics & Rankings

Price returns through October 16, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.

Financial Highlights

—
Revenue (latest FY)
—
Net Income (latest FY)
—
Operating Cash Flow

Upcoming Events

JAN
01
January 1, 2027 - March 31, 2027 Regulatory

510(k) submission

Target 510(k) submission for Ten Minute Tissue in Q1 2027 seeking clearance vs a predicate device; supporting studies ongoing.
JAN
01
January 1, 2027 - March 31, 2027 Regulatory

510(k) FDA submission

Targeted 510(k) FDA submission for CXU wound care device in Q1 2027; CDMO scale-up, packaging and sterilization work.
JAN
01
January 1, 2027 - March 31, 2027 Regulatory

510(k) submission

Targeting 510(k) submission for lead CXU™ candidate via predicate pathway in Q1 2027; subject to testing, manufacturing.
JAN
01
January 1, 2027 - March 31, 2027 Regulatory

510(k) submission

Conexeu plans to submit a 510(k) to FDA for Ten Minute Tissue in Q1 2027 to support regulatory clearance efforts.
JAN
01
January 1, 2027 - April 30, 2027 Regulatory

510(k) submission

Anticipated predicate-based 510(k) submission in the U.S. for Conexeu's initial indication; targeted timing early 2027 (Jan 1–Apr 30).

Conexeu Sciences has 5 upcoming scheduled events. The next event, "510(k) submission", is scheduled for January 1, 2027 (in 75 days). Investors can track these dates to stay informed about potential catalysts that may affect the CNXU stock price.

Short Interest History

Last 12 Months

Short interest in Conexeu Sciences (CNXU) currently stands at 210.5 thousand shares, up 22.3% from the previous reporting period, representing 1.5% of the float. Since May 2026, short interest has increased by 872.7%.

Days to Cover History

Last 12 Months

Days to cover for Conexeu Sciences (CNXU) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume.

CNXU Company Profile & Sector Positioning

Conexeu Sciences (CNXU) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.

Frequently Asked Questions

What is the current stock price of Conexeu Sciences (CNXU)?

The current stock price of Conexeu Sciences (CNXU) is $3.15 as of October 16, 2026.

What is the market cap of Conexeu Sciences (CNXU)?

The market cap of Conexeu Sciences (CNXU) is approximately $88.9M. Learn more about what market capitalization means .